Today’s Forbes Daily newsletter covers the billionaires backing Zohran Mamdani, a hampered CFPB, Reddit's most profitable quarter yet, Jeff Bezos gets a boost and more.

Vir Biotechnology, Inc. today announced the completion of enrollment for ECLIPSE 1, a Phase 3 trial evaluating the safety and efficacy of the combination of tobevibart and elebsiran in patients with ...

GIB (NYSE)cgi.com/newsroom MONTRÉAL, Nov. 3, 2025 /PRNewswire/ - CGI Inc. (NYSE: GIB) (TSX: GIB.A), one of the largest ...